A Study to Assess Analgesic Efficacy of Intravenous Lignocaine

Effect of Perioperative Systemic Lignocaine on Postoperative Pain in Patients Undergoing Elective Open Abdominal Surgeries- a Double Blinded Randomized Control Trial

The primary objectives of this study are to analyse the effect of perioperative systemic infusion of lignocaine on postoperative pain, postoperative nausea and vomiting and perioperative levels of inflammatory mediators in patients undergoing elective open abdominal surgeries.

The secondary parameters which will be observed during the study are the time to passage of flatus and stools postoperatively.

Study Overview

Detailed Description

Patients will be randomized into two groups- A and B, to receive an intravenous infusion of lignocaine or saline,respectively, as a bolus of 1.5mg/kg at the time of intubation followed by an infusion at a rate of 1.5mg/kg/hr continued throughout the surgery and till one hour postop. Postoperative analgesia will be provided through Patient Controlled Analgesia (PCA) pump providing morphine. Postoperative pain scores will be noted at immediate postoperative and at 6, 18, 24 hours post surgery. The number of PCA demands and cumulative morphine consumption till 24 hours post surgery will be noted. The incidence of postoperative nausea and vomiting is recorded. The time to first passage of flatus and stools postoperatively will be noted. Levels of total leukocyte count, c-reactive protein (CRP) and interleukin-6(IL-6) will be noted in preoperative, immediate post operative and 24 hours post surgery.

Study Type

Interventional

Enrollment (Actual)

134

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Puducherry, India, 605006
        • Jawaharlal Institute Of Postgraduate Medical Education And Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients above 18 years of age
  • undergoing elective open abdominal surgeries
  • belonging to the American Society of Anaesthesiologists (ASA)status I,II,III

Exclusion Criteria:

  • patients sensitive to lignocaine,
  • patients suffering from cardiovascular diseases or with preoperative changes on electrocardiogram
  • patients on beta blocker drugs
  • patients on opioid drugs for prolonged period
  • patients with functional bowel disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: intravenous lignocaine
Intravenous lignocaine will be given as a bolus of 1.5mg/kg at the time of intubation followed by an infusion at a rate of 1.5mg/kg/hr throughout surgery and till one hour post surgery.
Intravenous lignocaine infusion is given in intraoperative period and till one hour post surgery.
Other Names:
  • Lidocaine, Xylocard
Placebo Comparator: normal saline
Normal saline will be given as a bolus at the time of intubation and saline infusion given to patients in the control group during the surgery and till one hour post surgery.
Intravenous lignocaine infusion is given in intraoperative period and till one hour post surgery.
Other Names:
  • Lidocaine, Xylocard

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
postoperative pain scores using visual analogue scale
Time Frame: till 24 hours post surgery
Postoperative pain scores are assessed in the patients using a visual analogue scale in the first 24 hours post surgery
till 24 hours post surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of patient controlled analgesia demands
Time Frame: Till 24 hours post surgery
The total number of times the patient presses the demand button of PCA pump are noted.
Till 24 hours post surgery
Total amount of morphine consumed
Time Frame: till 24 hours post surgery
The total morphine consumption till 24 hours post surgery is noted.
till 24 hours post surgery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perioperative levels of inflammatory mediators
Time Frame: in preoperative period, immediate post op and 24 hours post surgery
Blood samples will be collected for the analysis of total leukocyte count, C-reactive protein and Interleukin-6 levels in the preoperative period, immediate postoperative and at 24 hours post surgery.
in preoperative period, immediate post op and 24 hours post surgery
time of passage of flatus and stools postoperatively
Time Frame: till postoperative day 7
Postoperative bowel function recovery will be assessed by noting the time of first passage of flatus and stools postoperatively
till postoperative day 7

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: parnandi sridhar, MBBS, Junior resident,JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH, PUDUCHERRY, INDIA

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2011

Primary Completion (Actual)

August 1, 2012

Study Completion (Actual)

August 1, 2012

Study Registration Dates

First Submitted

September 26, 2012

First Submitted That Met QC Criteria

October 3, 2012

First Posted (Estimate)

October 4, 2012

Study Record Updates

Last Update Posted (Estimate)

October 4, 2012

Last Update Submitted That Met QC Criteria

October 3, 2012

Last Verified

October 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe